This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Albany International(AIN) was upgraded to buy at TheStreet Ratings.
Ametek(AME) was upgraded at Citigroup to buy from neutral. The setup for stock-moving M&A is becoming more favorable, Citi said. Price target goes to $48.
CA(CA - Get Report) was downgraded at Oppenheimer to perform from outperform. Valuation call, as the company's restructuring will limit growth, Oppenheimer said.
Crestwood Midstream(CMLP) was downgraded at UBS to neutral from buy. The merger with
Inergy Midstream(NRGM) creates synergies and improves capital costs, but the shares are fully valued, UBS said. Price target goes to $25.
GNC Acquisition(GNC) was downgraded to hold at TheStreet Ratings.
IDEX(IEX) was downgraded at Citigroup to neutral from buy. The stock is trading at a premium to the group and is above its historical range, Citi said.
Louisiana-Pacific(LPX - Get Report) was upgraded at DA Davidson to neutral from underperform. $19 price target. Company is doing the best it has done since the housing boom, DA Davidson said.
Lululemon(LULU - Get Report) was upgraded at Sterne Agee to buy. $90 price target. Estimates were also boosted, following recent meetings with management, Sterne Agee said.
Time Warner Telecom(TWTC) was downgraded at Oppenheimer to perform from outperform. Company cut its growth guidance, Oppenheimer said.
ValueClick(VCLK) was downgraded at Cantor Fitzgerald to hold from buy. $31 price target. Sales growth is decelerating, Cantor Fitzgerald said.
Vitamin Shoppe(VSI) was downgraded at Bank of America/Merrill Lynch to underperform from neutral. Estimates were also cut, as the company is facing increased competition, BofA/Merrill said. $40 price target.
Zillow(Z) was downgraded at Goldman Sachs to neutral from buy. Valuation call, based on a $67 price target, Goldman Sachs said.
STOCK COMMENTS / EPS CHANGES
American Capital(ACAS) estimates were reduced at UBS. Disappointing quarter for origination and spread, UBS said.
Aetna(AET) price target and estimates were increased at UBS. Reflects the CVH deal and a reduction in the debt-to-capital ratio, said UBS. Price target goes to $68.
Aruba Networks(ARUN) numbers were cut at JMP Securities. Estimates were reduced through 2014. Company lowered its guidance. Outperform rating and new $21 price target.